Skip to content
Tenfell
Awarded contract
Published 03 May 2019

NHS Framework agreement for Branded Medicines - North of England - Tranche A

NHS England · London

Key facts

Awarded
18 Feb 2019
Contract starts
01 Mar 2019
Contract ends
28 Feb 2021
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 25 suppliers

SupplierValue
Takeda UK Limited—
Pfizer Ltd—
MSD—
Abbvie Ltd—
Amgen Ltd—
Sandoz Ltd—
Accord-UK Ltd—
Eli Lilly & Company Ltd—
Ipsen—
Merck Serono Limited—
Novartis Pharmaceuticals UK Ltd—
Novo Nordisk—
ViiV Healthcare UK Ltd—
TEVA PHARMACEUTICALS—
Pharmacosmos UK Ltd—
Vifor Pharma UK Limited—
Janssen Limited—
Allergan Limited—
Merz Pharma UK Ltd—
BMS LIMITED—
CHUGAI PHARMA U.K. LTD.—
FERRING LTD—
GILEAD LTD—
NAPP PHARMACEUTICAL GROUP LIMITED—
ROCHE PHARMACEUTICALS LIMITED—

Description

NHS Framework for North of England, Branded Medicines - Tranche A

CM/PHR/16/5526/01- 1 March 2019 to 28 February 2021 (Option to extend for up to 24 months)

CM/PHR/16/5526/02- 1 March 2019 - 29 February 2020 (option to extend for up to 12 months)

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.